US 8911733
Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
granted A61KA61K2039/505A61P
Quick answer
US patent 8911733 (Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/16, A61P11/00